| Cellular uptake, cytotoxicity, apoptosis, DNA-binding, photocleavage and molecular docking studies of ruthenium (II) polypyridyl complexes A Srishailam, YP Kumar, PV Reddy, N Nambigari, U Vuruputuri, SS Singh, ... Journal of Photochemistry and Photobiology B: Biology 132, 111-123, 2014 | 73 | 2014 |
| Selective ATP competitive leads of CDK4: Discovery by 3D-QSAR pharmacophore mapping and molecular docking approach R Rondla, LS PadmaRao, V Ramatenki, A Haredi-Abdel-Monsef, ... Computational biology and chemistry 71, 224-229, 2017 | 29 | 2017 |
| Identification of novel antagonists for Rab38 protein by homology modeling and virtual screening A Haredi Abdelmonsef, R Dulapalli, T Dasari, L Souda Padmarao, ... Combinatorial chemistry & high throughput screening 19 (10), 875-892, 2016 | 29 | 2016 |
| Homology modeling and virtual screening of ubiquitin conjugation enzyme E2A for designing a novel selective antagonist against cancer V Ramatenki, SR Potlapally, RK Dumpati, R Vadija, U Vuruputuri Journal of Receptors and Signal Transduction 35 (6), 536-549, 2015 | 27 | 2015 |
| Identification of novel selective antagonists for cyclin C by homology modeling and virtual screening PS Rajender, M Vasavi, U Vuruputuri International Journal of Biological Macromolecules 48 (2), 292-300, 2011 | 25 | 2011 |
| Design of novel lead molecules against RhoG protein as cancer target–a computational study T Dasari, B Kondagari, R Dulapalli, AH Abdelmonsef, T Mukkera, ... Journal of Biomolecular Structure and Dynamics 35 (14), 3119-3139, 2017 | 24 | 2017 |
| Identification of novel leads applying in silico studies for Mycobacterium multidrug resistant (MMR) protein V Malkhed, KK Mustyala, SR Potlapally, U Vuruputuri Journal of Biomolecular Structure and Dynamics 32 (12), 1889-1906, 2014 | 18 | 2014 |
| Azolium analogues as CDK4 inhibitors: Pharmacophore modeling, 3D QSAR study and new lead drug discovery R Rondla, LSP Rao, V Ramatenki, R Vadija, T Mukkera, SR Potlapally, ... Journal of Molecular Structure 1134, 482-491, 2017 | 17 | 2017 |
| Structure-based drug design, synthesis and screening of MmaA1 inhibitors as novel anti-TB agents H Veeravarapu, V Malkhed, KK Mustyala, R Vadija, R Malikanti, ... Molecular Diversity 25, 351-366, 2021 | 15 | 2021 |
| Study of interactions between Mycobacterium tuberculosis proteins: SigK and anti-SigK V Malkhed, B Gudlur, B Kondagari, R Dulapalli, U Vuruputuri Journal of molecular modeling 17, 1109-1119, 2011 | 14 | 2011 |
| Identification of new lead molecules against UBE2NL enzyme for cancer therapy V Ramatenki, R Dumpati, R Vadija, S Vellanki, SR Potlapally, R Rondla, ... Applied Biochemistry and Biotechnology 182, 1497-1517, 2017 | 13 | 2017 |
| Homology modeling and virtual screening studies of FGF-7 protein—a structure-based approach to design new molecules against tumor angiogenesis R Vadija, KK Mustyala, N Nambigari, R Dulapalli, RK Dumpati, ... Journal of chemical biology 9, 69-78, 2016 | 13 | 2016 |
| Suppressor of cytokine signalling‐3 as a drug target for type 2 diabetes mellitus: a structure‐guided approach R Dumpati, R Dulapalli, B Kondagari, V Ramatenki, S Vellanki, R Vadija, ... ChemistrySelect 1 (10), 2502-2514, 2016 | 11 | 2016 |
| Pharmacophore mapping and in silico screening to identify new potent leads for A2A adenosine receptor as antagonists KK Mustyala, AR Chitturi, PS Naikal James, U Vuruputuri Journal of Receptors and Signal Transduction 32 (2), 102-113, 2012 | 11 | 2012 |
| Virtual screening studies to identify novel inhibitors for Sigma F protein of Mycobacterium tuberculosis KK Mustyala, V Malkhed, VR Chittireddy, U Vuruputuri International journal of mycobacteriology 4 (4), 330-336, 2015 | 10 | 2015 |
| Macromolecular structure and interaction studies of SigF and Usfx in Mycobacterium tuberculosis KK Mustyala, V Malkhed, SR Potlapally, VR Chittireddy, U Vuruputuri Journal of Receptors and Signal Transduction 34 (3), 162-173, 2014 | 10 | 2014 |
| Structural evaluation and binding mode analysis of CCL19 and CCR7 proteins—identification of novel leads for rheumatic and autoimmune diseases: an insilico study SP Vellanki, R Dulapalli, B Kondagari, N Nambigari, R Vadija, ... Interdisciplinary Sciences: Computational Life Sciences 10, 346-366, 2018 | 9 | 2018 |
| Identification of small molecular ligands as potent inhibitors of fatty acid metabolism in Mycobacterium tuberculosis R Malikanti, R Vadija, H Veeravarapu, KK Mustyala, V Malkhed, ... Journal of Molecular Structure 1150, 227-241, 2017 | 9 | 2017 |
| Targeting the ubiquitin-conjugating enzyme E2D4 for cancer drug discovery–a structure-based approach V Ramatenki, R Dumpati, R Vadija, S Vellanki, SR Potlapally, R Rondla, ... Journal of chemical biology 10, 51-67, 2017 | 9 | 2017 |
| Modeling of alternate RNA polymerase sigma D factor and identification of novel inhibitors by virtual screening V Malkhed, KK Mustyala, SR Potlapally, U Vuruputuri Cellular and Molecular Bioengineering 5, 363-374, 2012 | 7 | 2012 |
